MINNEAPOLIS--Punch & Associates intends to vote AGAINST proposed acquisition of Avid Bioservices, Inc. by GHO Capital and Ampersand Capital.

Bluebird Bio (BLUE) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.66 per share a year ago. These figures are ...

NEW YORK CITY, NY / ACCESSWIRE / November 13, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered ...

On Tuesday, Avid Bioservices Inc (CDMO) stock saw a decline, ending the day at $12.23 which represents a decrease of $-0.02 or -0.16% from the prior close of $12.25. The stock opened at $12.25 and ...

Corporate SecretaryAvid Bioservices, Inc.14191 Myford RoadTustin, CA 92780 Dear Board of Directors, My name is Prasad Phatak and I am writing to you in ...

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders ...

Private equity investors GHO Capital Partners and Ampersand Capital Partners have announced a merger agreement for the ...

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and ...

Blackstone (BX) agreed to acquire Retail Opportunity Investments (ROIC) in an all-cash deal valued at ~$4B, incl ...

We are bullish on Avid's potential take-private deal by Ampersand and GHO, predicting value creation and optimistic about ...

Private equity groups have bought several smaller specialised contract manufacturers this year, including FairJourney ...

November 8, 2024) - Rigrodsky Law, P.A. is investigating Avid Bioservices, Inc. ("Avid") (NASDAQ CM: CDMO) regarding possible breaches of fiduciary duties and other violations of law related to Avid's ...